This study also showed that IgE-mediated mast cell activation might occur in the context of background endogenous AhR activity in vivo, suggesting that the blockade of the AhR signaling by EC might be beneficial for allergic diseases involving IgE and mast cells. This evidence concerns the gene IGHE and allergic disease.